N899 300
Pill imprint N899 300 has been identified as Nizatidine 300 mg.
Nizatidine is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Nizatidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Nizatidine Images
- Imprint:
-
N899
300 - Strength:
- 300 mg
- Color:
- Beige
- Size:
- 19.00 mm
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- gelatin
silicon dioxide
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
ferric oxide red
magnesium stearate
sodium lauryl sulfate
magnesium silicate
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-1066
Advertisement
More Nizatidine resources
- Nizatidine (Wolters Kluwer)
- Nizatidine Solution (Wolters Kluwer)
- nizatidine (Cerner Multum)
- Nizatidine (AHFS DI)
- Nizatidine (FDA)
- Nizatidine Solution (FDA)
- Nizatidine (Wolters Kluwer)
Search Again
